ArticleBMJ open2025
Human papillomavirus vaccine uptake and associated factors among in-school adolescent girls in Harari regional state, Eastern Ethiopia: a cross-sectional study.
Article in BMJ open, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Uptake of human papillomavirus vaccine among school girls and its associated factors in Addis Ababa, Ethiopia.SAGE open medicine · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveThe Human Papillomavirus (HPV) vaccine has offered a great promise to reduce the cervical cancer burden, yet its uptake remains limited, and the current evidence is mixed and inconclusive. This study aims to assess HPV vaccine uptake and its associated factors among adolescent school girls.
designA school-based cross-sectional study.
settingSchools in Harari regional state, Eastern Ethiopia.
participantstotal of 416 female adolescent students, from 1 April 2024 to 30 April 2024. OUTCOME: Uptake of HPV vaccination.
methodsA multi-stage sampling technique was used to select study participants. A structured interviewer-administered questionnaire was used for data collection. The collected data were entered into Epidata V.3.1 and analysed by using STATA V.17.0. A logistic regression model was used to assess the associations between dependent and independent variables. An adjusted OR with 95% CIs was used to declare a significant association.
resultAdolescent girls' uptake of the HPV vaccine was 49.26% (95% CI 42.65% to 56.59%) Being urban residents (AOR=2.59; 95% CI 1.61 to 4.18), having a government-employed mother (AOR=2.60; 95% CI 1.12 to 6.05), availability of health promotion in their vicinity (AOR=4.17; 95% CI 2.01 to 8.66), having a good knowledge of cervical cancer and HPV infection (AOR=1.64; 95% CI 1.05 to 2.57) were significantly associated with uptake of HPV vaccine
conclusionNearly half of the eligible in-school adolescent girls received the HPV vaccine. Being an urban resident, having a government-employed mother, the availability of health promotion in their vicinity, and having a good knowledge of cervical cancer and HPV infection were significantly associated with the uptake of HPV vaccination. Expanding health promotion and raising awareness of cervical cancer and HPV infection among rural adolescents could increase HPV vaccine uptake.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.